Biography of Thomas Wiggans
Last update: November 17, 2023Career
Thomas was Venture Partner at Clarus, and Chief Executive Officer and Chairman of the Board at Monogram Biosciences. Thomas Wiggans joined Annexon in 2023.
Thomas Wiggans is currently- Chief Executive Officer and Chairman of the Board at Pardes Biosciences - View - Pardes Biosciences org chart
- Chairman of the Board at Annexon - View - Annexon org chart
- Chairman of the Board at Jasper Therapeutics - View - Jasper Therapeutics org chart
- Director at CymaBay Therapeutics - View - CymaBay Therapeutics org chart
Create your alert
to follow the career of Thomas Wiggans.
Education
In 1976, Thomas Wiggans completed a Master of Business Administration at Southern Methodist University.
They have also studied at Southern Methodist University :
Find more alumni from Southern Methodist University
More about Thomas Wiggans
Selected links
Do you need to know more about Thomas Wiggans? More results.
Participate
Social media
- Thomas Wiggans on Google News, Twitter, LinkedIn, YouTube
- View the pictures of Thomas Wiggans
The colleagues of Thomas Wiggans
Company Colleagues
- At Pardes Biosciences, Thomas Wiggans has 11 colleagues including Deborah Autor (Director), Mark Auerbach (Director)…
- At Annexon, Thomas Wiggans has 13 colleagues including Douglas Love (CEO & Director), Jung Choi (Director)…
- At Jasper Therapeutics, Thomas Wiggans has 17 colleagues including Ronald Martell (CEO & Director), Anna French (Director)…
- At CymaBay Therapeutics, Thomas Wiggans has 15 colleagues including Sujal Shah (CEO & Director), Robert Wills (Chairman of the Board)…
Industry Colleagues
- In the Biotechnology industry, Thomas Wiggans has 30,266 colleagues in 2,283 companies located in 40 countries. 14,433 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Thomas Wiggans.
Get in Touch
and ask for Thomas Wiggans.
